CVS Health (MEX:CVS) ROCE %: 11.38% (As of Mar. 2026)


MEX:CVS CVS Health Corp MEX:CVS
70 GF Score
Price MXN1,787.51
GF Value MXN1,326.88
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is CVS Health ROCE %?

CVS Health MEX:CVS 70 ROCE % is 11.38% as of Mar. 2026. GuruFocus rates MEX:CVS with a GF Score™ of 70/100 and a GF Value™ of MXN1,326.88 (Significantly Overvalued). The stock has 10 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CVS Health's annualized ROCE % for the quarter that ended in Mar. 2026 was 11.38%.

CVS Health  (MEX:CVS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CVS Health ROCE % Related Terms

CVS Health ROCE % Historical Data

* Premium members only.

The historical data trend for CVS Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVS Health ROCE % Chart

CVS Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.93 4.88 7.84 5.92 2.92

CVS Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.04 5.58 -6.52 5.18 11.38
MEX:CVS
70GF Score
CVS Health Corp MEX:CVS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVS Health ROCE % Calculation

CVS Health's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=94619.954/( ( (5280976.072 - 1764579.92) + (4565129.169 - 1596961.545) )/ 2 )
=94619.954/( (3516396.152+2968167.624)/ 2 )
=94619.954/3242281.888
=2.92 %

CVS Health's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=339880.328/( ( (4565129.169 - 1596961.545) + (4561804.254 - 1558133.477) )/ 2 )
=339880.328/( ( 2968167.624 + 3003670.777 )/ 2 )
=339880.328/2985919.2005
=11.38 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 11.38% mean?
CVS Health (MEX:CVS) has a ROCE % of 11.38% as of Mar. 2026.
Is CVS Health's ROCE % too high?
CVS Health's current ROCE % is 11.38%. The Healthcare Plans industry median ROCE % is 9.38. CVS Health's value of 11.38% is 21.3% above this industry median. Overall, CVS Health has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CVS Health's ROCE % compare to ELV and CI?
CVS Health's ROCE % of 11.38% can be compared against companies in the Healthcare Plans industry. The industry median ROCE % is 9.38. CVS Health's value of 11.38% is 21.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Plans company?
The median ROCE % among Healthcare Plans companies is 9.38, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Health's current ROCE % of 11.38% is 21.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Plans industry, the median ROCE % is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Health's current ROCE % is 11.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
Based on GuruFocus' analysis, CVS Health (MEX:CVS) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN1,326.88, compared to a current price of MXN1,787.51 — trading 34.7% above its estimated fair value. The current ROCE % is 11.38% and 21.3% above the Healthcare Plans industry median of 9.38. CVS Health's overall GF Score™ is 70/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For CVS Health (MEX:CVS), the current ROCE % is 11.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVS Health (MEX:CVS) Overvalued in 2026?

Based on GuruFocus' analysis, CVS Health stock appears to be overvalued. The current stock price of MXN1,787.51 is trading 34.7% above its estimated GF Value™ of MXN1,326.88. GuruFocus considers CVS Health to be Significantly Overvalued.

Key valuation signals for MEX:CVS:

  • ROCE %: 11.38%
  • GF Value™: MXN1,326.88 vs. price of MXN1,787.51 (34.7% above fair value)
  • GF Score™: 70/100 with 10 warning signs
  • Industry Position: 21.3% above the Healthcare Plans median

No single metric tells the full story. See the MEX:CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVS Health Business Description

Address One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
70GF Score

Get the complete analysis for MEX:CVS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,787.51
Price
MXN1,326.88
GF Value